ERBB2 and breast carcinoma: Wang et al. have recently reported that γ-TT can inhibit OXPHOS in gastric adenocarcinoma cells by targeting mitochondrial complex I and II, while δ-TT suppressed mitochondrial activity and ATP production in HER-2 overexpressing breast cancer [39, 40].